MRNA

Moderna

$22.36

-2.56 (-10.27%)
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...

Analyst Overview

Target Price:
Date: 20.11.2025
$39.79
(+77.95%)
Strong Buy: 2
Buy: 3
Hold: 15
Sell: 1
Strong Sell: 3
Description:
Moderna, Inc. is a pioneering biotechnology company based in Cambridge, Massachusetts, recognized for its innovative approach to messenger RNA (mRNA) technology in vaccine and therapeutic development. Gaining global prominence for its role in delivering one of the first successful COVID-19 vaccines, Moderna is now strategically expanding its portfolio to target a wide array of health challenges, including immuno-oncology, rare diseases, cardiovascular conditions, and autoimmune disorders. With a commitment to advancing healthcare through cutting-edge research and a strong product pipeline, Moderna seeks to redefine the future of medicine and address unmet medical needs on a global scale.
Exchange:
NASDAQ
Country:
USA
Sector:
HEALTHCARE
Industry:
BIOTECHNOLOGY
Address:
325 BINNEY STREET, CAMBRIDGE, MA, UNITED STATES, 02142
Fiscal year end:
December
Market capitalization:
$9.74 Billion
EBITDA:
-$3.26 Billion
PERatio:
0.0
EPS:
-8.11
Dividend per share:
$0.00
Dividend yield:
0.0%
Beta:
1.111

Dividends for 10 years

Loading...

Income Statements for 10 years

Loading...
Loading...

Earnings calender

Loading...

Income count if spend 1000$ ten years ago on shares

How much was you spent on shares:
$1,000
How much will you earn in 7 years:
+46%
How much will you get:
$1,460
Prices dates:
07-12-2018: $18.60 and 31-10-2025: $27.16